Brain neoplasm malignant and Neoplasm recurrence

Summary:

Neoplasm recurrence is found among people with Brain neoplasm malignant, especially for people who are female, 40-49 old.

The study analyzes which people have Neoplasm recurrence with Brain neoplasm malignant. It is created by eHealthMe based on reports of 12 people who have Brain neoplasm malignant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Brain neoplasm malignant?

Brain neoplasm malignant (brain cancer tumour) is found to be associated with 244 drugs and 273 conditions by eHealthMe. Check the latest studies of Brain neoplasm malignant.

What is Neoplasm recurrence?

Neoplasm recurrence (reoccurrence of tumour) is found to be associated with 357 drugs and 495 conditions by eHealthMe. Check the latest studies of Neoplasm recurrence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

12 people who have Brain Neoplasm Malignant and Neoplasm Recurrence are studied.

Would you have Neoplasm recurrence when you have Brain neoplasm malignant?

Gender of people who have Brain Neoplasm Malignant and experienced Neoplasm Recurrence *:

female: 60 %
male: 40 %

Age of people who have Brain Neoplasm Malignant and experienced Neoplasm Recurrence *:

Common co-existing conditions for these people *:

Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 2 people, 16.67%
Brain Neoplasm (tumour of brain): 1 person, 8.33%

Common drugs taken by these people *:

Common symptoms for these people *:

Brain Neoplasm (tumour of brain): 4 people, 33.33%
White Blood Cell Count Decreased: 2 people, 16.67%
Hydrocephalus (water on the brain): 2 people, 16.67%
Speech Impairment (Adult) (inability to speak (adult)): 2 people, 16.67%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 16.67%
Paresis (a condition of muscular weakness): 2 people, 16.67%
Malignant Neoplasm Progression (cancer tumour came back): 2 people, 16.67%
Hemianopia Homonymous (visual field defect involving either the two right or the two left halves of the visual fields of both eyes): 2 people, 16.67%
Nausea And Vomiting: 2 people, 16.67%
Dysphemia (stammering or stuttering): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Neoplasm recurrence?

- Check whether Neoplasm recurrence is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Neoplasm recurrence and Brain neoplasm malignant, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.